Home › Free Stock Grades › GLSI
Greenwich LifeSciences, Inc. (GLSI) Stock Grade
GLSI · Healthcare
C
Market Cap
$272.9M
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
—
Dividend Yield
None
About Greenwich LifeSciences, Inc.'s fundamentals
Greenwich LifeSciences is a biotechnology company with a market capitalization of $272.9 million that is currently unprofitable, reporting a net loss in its latest annual statement and a net margin of 0.0%. The company generated zero revenue growth year-over-year and does not pay a dividend. As a pre-revenue or early-stage biotech firm, traditional valuation metrics like P/E ratio and return on equity are not applicable, which is typical for development-stage companies focused on research and drug development rather than near-term earnings.